PCV2 vaccines
This article describes the main characteristics of commercial vaccines to combat swine circovirosis.
Porcine circovirus is caused by porcine circovirus type 2 (PCV2) and has a huge economical impact. Clinically it is presented as a disease which deteriorates animals from the weaning to the finishing period producing a high mortality rate. It also causes dermatitis and nephropathia with high mortality.
Alternative names: Porcine circovirosis type 2 (PCV2), PMWS,(PDNS
Porcine circovirosis is caused by porcine circovirus type 2 (PCV2). Clinically it is presented as a disease which deteriorates animals from the weaning to the finishing period producing a high mortality rate. The virus is ubiquitous globally. It is very small and very resistant to the environment. There are two serotypes: Type 1, which does not cause any known disease, and Type 2, which causes disease in pigs. Recently a new serotype, PCV3, has been described however its etiologic role in PCVAD needs further investigation. Although the PCV2 has been present in pigs for several years without any clinical manifestation, a mutation or an introduction of a new strain caused a deterioration syndrome with high mortality. There are several different strains (PCV2a, PCV2b, PCV2c, etc.), although vaccines that have the first known strains seem to give adequate protection against all the strains.
A special sign of PCV2 is the dermatitis and nephropathy porcine syndrome. This syndrome appears mainly in growing and finishing pigs, and rarely affects other groups. As its name indicates, its clinical presentation is through skin lesions and affects the kidneys. Possibly the clinical signs appear eventually in a small number of animals. Mortality of affected pigs is almost 100%.
Sows and lactating piglets
Weaners and growers
This article describes the main characteristics of commercial vaccines to combat swine circovirosis.